The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren's syndrome-like sialadenitis

Modern Rheumatology

Volumn 23, Issue 3, 2013, Pages 614-616

  Iizuka, Mana ^a   Tsuboi, Hiroto ^a   Matsuo, Naomi ^a   Kondo, Yuya ^a   Asashima, Hiromitsu ^a   Matsui, Minoru ^b   Matsumoto, Isao ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tokyo Nishi Tokushukai Hospital   (Japan)

Author keywords

Apoptosis; IFN ; M3 muscarinic acetylcholine receptor; Sialadenitis; Sj gren's syndrome

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; MUSCARINIC M3 RECEPTOR;

APOPTOSIS; ARTICLE; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIALOADENITIS; SJOEGREN SYNDROME; T LYMPHOCYTE;

ANIMALS; INTERFERON-GAMMA; MICE; MICE, KNOCKOUT; RECEPTOR, MUSCARINIC M3; SIALADENITIS;

EID: 84877773390     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0785-8     Document Type: Article

References (10)

1. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugihara T, Matsumura R, et al. Muscarinic acetylcholine receptor autoantibodies in patient with Sjögren's syndrome. Ann Rheum Dis. 2005;64:510-1.
2. Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Clin Exp Immunol. 2010;162(1):53-61.
3. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers N, Smith M. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006;54:1165-73.
4. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, et al. Altered peptide ligand regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome. Ann Rheum Dis. 2006;65:269-71.
5. Mitsias DI, Tzioufas AG, Veiopoulou C, Zintaras E, Tassios K, Kogopoulou O, et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol. 2002;128(3):562-8.
6. Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, et al. Overexpression of phosphorylated STAT-1 alpha in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2006;54(11):3476-84.
7. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008;181(4):2898-906.
8. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. J Autoimmun. 2010;35(4):383-9.
9. Xu X, Fu XY, Plate J, Chong A. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998;58(13):2832-7.
10. Bulosan M, Pauley KM, Yo K, Chan E, Katz J, Peck AB, et al. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset. Immunol Cell Biol. 2009;87(1):81-90.